LEP and breast carcinoma: The aim of the current study was to evaluate the role of leptin, as a mediator of the tumor-stroma interaction, in regulating breast CSC activity using breast cancer cell lines and patient-derived breast cancer cells isolated from metastatic ascites and pleural effusions.